Technology | 2010.08.10
ACADIA Pharmaceuticals Reports Second Quarter 2010 Financial Results
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the second quarter ended June 30, 2010. ACADIA reported a net loss of $4.3 million, or $0.11 per common share, for the second quarter of 2010 compared to a net loss of $12.7 million, or $0.34 per common share, fo
For more information, please visit
http://www.businesswire.com/news/home/20100809006619/en
Follow us on
📊 Most Viewed News
- • The complete guide to making your product international - The Nex... (15,540)
- • Colaboração 2.0: Breaking Down the Language Barrier - Business ... (12,033)
- • A Start-Up Bets on Human Translators Over Machines - New York Tim... (11,530)
- • Immigrants 'should learn English' - Politics.co.uk (11,206)
- • How OpenStack gets translated - opensource.com (11,042)
- • easyJet Chooses TransPerfect for Pan-European Translation - Busin... (10,934)
- • Para-Plus Translations Honored by Philadelphia Business Journal .... (10,367)
- • Google Adds Customized Translations for Website Owners - PC Magaz... (10,257)